China has become the first country in the world to approve Roche’s anti-complement C5 antibody crovalimab, the first treatment for rare disorder paroxysmal nocturnal haemoglobinuria (PNH) that can be given by subcutaneous injection.
Copyright © 2024 | WordPress Theme by MH Themes